4.6 Article

Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy

Related references

Note: Only part of the references are listed.
Article Allergy

Efficacy and safety of food allergy oral immunotherapy in adults

Na'ama Epstein-Rigbi et al.

Summary: Oral immunotherapy (OIT) is successful in desensitizing most adults with IgE-mediated food allergy. However, adults undergoing milk OIT are at increased risk for severe reactions and treatment failure.

ALLERGY (2023)

Letter Allergy

Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity

C. Castenmiller et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Article Allergy

Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy

Justine Calise et al.

Summary: This study found that inherent qualities of cell response at baseline can influence the response to peanut oral immunotherapy in peanut-allergic individuals. Peanut allergy can be broadly classified into at least two subtypes based on the proportion of specific T-cell subsets, with distinct immunologic and clinical characteristics. Stratifying patients based on their peanut-specific T-cell profile may help identify which immunotypes will respond best to different therapies in clinical settings.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Allergy

Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts

M. Cecilia Berin et al.

Summary: This study examined the relationship between food allergen-specific T-cell response and food allergy. It found that food-specific type 2 T cells at baseline can predict the threshold of reactivity and response to immunotherapy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Allergy

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Jacqueline A. Pongracic et al.

Summary: In a study designed to mimic real-world use, VP250 was found to be well tolerated in peanut-allergic children, consistent with previous research.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Allergy

Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses

Veronique Bajzik et al.

Summary: By studying individuals with peanut allergy undergoing oral desensitization immunotherapy, researchers found that this treatment reduces allergic reactions to peanuts and reshapes T-cell responses to peanuts.

ALLERGY (2022)

Article Medicine, Research & Experimental

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells

Brinda Monian et al.

Summary: This study used single-cell RNA-Seq to investigate the dynamic changes in T cells of 12 peanut allergy patients during OIT. The results showed that specific T cell subsets play a crucial role in OIT, and the treatment outcomes are associated with individual characteristics and the expression of specific cell subsets during the treatment.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Allergy

The global burden of illness of peanut allergy: A comprehensive literature review

Jay A. Lieberman et al.

Summary: Peanut allergy (PA) affects around 2% of the general population in Western countries, leading to significant burden of self-management for patients and their families/caregivers. PA is associated with higher rates of accidental exposure, severe reactions, and potential fatal anaphylaxis compared to other food allergies, resulting in considerable healthcare utilization and economic costs.

ALLERGY (2021)

Review Allergy

Food allergy across the globe

Vanitha Sampath et al.

Summary: The prevalence of food allergy is increasing in some areas, calling for better strategies for prevention, diagnosis, and therapy. Significant progress has been made in understanding the causes of food allergies, leading to updated guidelines recommending early introduction of allergenic foods and the approval of oral immunotherapy drugs for FA.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Optimal human pathogenic TH2 cell effector function requires local epithelial cytokine signaling

Justine Calise et al.

Summary: IL-33 plays a role in modulating circulating allergen-specific T-cell responses, with ST2 expression specifically associated with T(H)2A cell activation. IL-33 selectively amplifies pathogenic T(H)2 cell effector functions in allergy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Immunology

Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation

Daniel F. Dwyer et al.

Summary: A comprehensive analysis of human MC hyperplasia in CRSwNP, a T2 cytokine-mediated inflammatory disease, was conducted using flow cytometry and single-cell RNA-sequencing. The study revealed distinct inflammation-associated effector programs of MCs, indicating that in situ MC proliferation is a major component of MC hyperplasia in human T2 inflammation.

SCIENCE IMMUNOLOGY (2021)

Review Immunology

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy

Guirong Liu et al.

Summary: The increasing prevalence of food allergies has spurred research on novel treatment strategies like EPIT, which has shown potential in inducing immune tolerance. Treg cells play a key role in immune tolerance induced by EPIT but further exploration is needed to understand its mechanism.

FRONTIERS IN IMMUNOLOGY (2021)

Article Allergy

Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity

Angelika Tscheppe et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

EAACI Allergen Immunotherapy User's Guide

Montserrat Alvaro-Lozano et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity

Eros Di Giorgio et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Immunology

Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy

Ann-Marie Malby Schoos et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Allergy

Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy

Daniel M. Moldaver et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Medicine, General & Internal

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial

David M. Fleischer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Medicine, Research & Experimental

Newly identified T cell subsets in mechanistic studies of food immunotherapy

Vanitha Sampath et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Allergy

The role of regulatory T cells in the acquisition of tolerance to food allergens in children

E. Bernaldo de Quiros et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2018)

Article Multidisciplinary Sciences

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation

Michihito Kono et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Medicine, General & Internal

AR101 Oral Immunotherapy for Peanut Allergy

Brian P. Vickery et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Allergy

Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis

Leticia Tordesillas et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Allergy

Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults

Stacie M. Jones et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

RORγt and RORα signature genes in human Th17 cells

Glenda Castro et al.

PLOS ONE (2017)

Review Allergy

Improving the safety of oral immunotherapy for food allergy

Marta Vazquez-Ortiz et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2016)

Letter Allergy

Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch

Stacie M. Jones et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Successful immunotherapy induces previously unidentified allergen-specific CD4+T-cell subsets

John F. Ryan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Allergy

Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy

S. R. Prickett et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2015)

Article Allergy

Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner

Erik Wambre et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Article Allergy

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy

Brian P. Vickery et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Review Medicine, Research & Experimental

Subsets of regulatory T cells and their roles in allergy

Huiyun Zhang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

Article Allergy

Ara h 1 CD4+T cell epitope-based peptides: candidates for a peanut allergy therapeutic

S. R. Prickett et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2013)

Article Allergy

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial

David M. Fleischer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Article Allergy

Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic

Sara R. Prickett et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Letter Allergy

Direct ex vivo analysis of allergen-specific CD4+ T cells

William W. Kwok et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Immunology

FOXP3 and the regulation of Treg/Th17 differentiation

Steven F. Ziegler et al.

MICROBES AND INFECTION (2009)

Article Food Science & Technology

Allergenic characteristics of a modified peanut allergen

N King et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2005)